DaxibotulinumtoxinA for Injection for the Management of Plantar Fasciitis

Inclusion Criteria: * Written informed consent, including authorization to release health information * Skeletally mature, male or female patients 18 to 65 years of age with diagnosis of plantar fasciitis * Persistent heel pain for more than three months * Women of child bearing potential must have a negative urine pregnancy test (UPT) at Screening Visit and must use an effective method of birth control during the course of the study Exclusion Criteria: * Previous surgery on the midfoot or hindfoot * Neuromuscular disease * Systemic muscle weakness * Planning a pregnancy during the study * Current enrollment in an investigational drug or device study or participation in such a study within the last 30 days prior to first visit